Works matching IS 03057453 AND DT 2008 AND VI 62 AND IP 0

Results: 4
    1

    Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 0, p. i17, doi. 10.1093/jac/dkn250
    By:
    • I. Florescu;
    • M. Beuran;
    • R. Dimov;
    • A. Razbadauskas;
    • M. Bochan;
    • G. Fichev;
    • G. Dukart;
    • T. Babinchak;
    • C. A. Cooper;
    • E. J. Ellis-Grosse;
    • N. Dartois;
    • H. Gandjini;
    • on behalf of the 307 Study Group
    Publication type:
    Article
    2

    A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 0, p. i29
    By:
    • Krasimir Vasilev;
    • Galina Reshedko;
    • Remus Orasan;
    • Miguel Sanchez;
    • Juri Teras;
    • Tim Babinchak;
    • Gary Dukart;
    • Angel Cooper;
    • Nathalie Dartois;
    • Hassan Gandjini;
    • Russ Orrico;
    • Evelyn Ellis-Grosse;
    • on behalf of the 309 Study Group
    Publication type:
    Article
    3
    4